miR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation

Area of Science:

• Molecular Biology
• Cardiovascular Biology
• Cellular Biology

Background:

• Cardiac autophagy is crucial for maintaining heart health and cellular homeostasis.
• Dysregulation of cardiac autophagy is linked to heart diseases like cardiac hypertrophy.
• The precise mechanisms controlling cardiac autophagy remain largely unidentified.

Purpose of the Study:

• To investigate the in vivo role of microRNA-199a (miR-199a) in regulating cardiac autophagy.
• To determine the involvement of miR-199a in the development of cardiac hypertrophy.
• To elucidate the molecular pathways through which miR-199a affects cardiomyocyte autophagy.

Main Methods:

• Generation of cardiac-specific miR-199a transgenic mice.
• Assessment of cardiomyocyte autophagy levels in vivo and in vitro.
• Analysis of the GSK3β/mTOR signaling pathway.
• Evaluation of hypertrophic markers and cardiac function.
• Intervention with autophagy modulators like rapamycin and Atg5 overexpression.

Main Results:

• Overexpression of miR-199a in the heart inhibited cardiomyocyte autophagy and induced cardiac hypertrophy.
• miR-199a impaired autophagy in a cell-autonomous manner by targeting the GSK3β/mTOR signaling pathway.
• Overexpression of autophagy-related gene 5 (Atg5) attenuated miR-199a-induced hypertrophy.
• Pharmacological activation of autophagy with rapamycin restored cardiac autophagy and reduced hypertrophy in miR-199a transgenic mice.

Conclusions:

• miR-199a acts as a critical regulator of cardiac autophagy and a driver of cardiac hypertrophy.
• Targeting miR-199a and modulating autophagy presents a potential therapeutic strategy for cardiac diseases.
• Understanding miR-199a's role provides new insights into the pathogenesis of heart failure.